| 1287 |
Centers for Disease Control and Prevention |
Html |
en |
Closure of Varicella-Zoster Virus-Containing VaccinesPregnancy Registry - United States, 2013 |
Mona Marin, MD1, English D. Willis, MD2, Ann Marko2, Sonja A. Rasmussen, MD3, Stephanie R. |
| pregnancy outcomes | 0.375319 |
| English D. Willis | 0.373155 |
| Drug Administration | 0.364833 |
| vaccine adverse event | 0.409547 |
| Stephanie R. Bialek | 0.372051 |
| Karen R. Broder | 0.358617 |
| registry enrollments | 0.343216 |
| vzv-containing vaccines | 0.565082 |
| pregnant women | 0.372841 |
| vaccine virus replication | 0.362181 |
| Ann Marko | 0.340659 |
| major birth defects | 0.363313 |
| Zoonotic Infectious Diseases | 0.358314 |
| health care providers | 0.362522 |
| varicella-susceptible women | 0.465714 |
| observed average rate | 0.355684 |
| sustained high coverage | 0.361309 |
| wild-type VZV | 0.431374 |
| small risk | 0.342787 |
| varicella vaccine | 0.397193 |
| National Center | 0.359038 |
| registry | 0.420824 |
| VZV-containing vaccine | 0.342295 |
| vaccine administrations | 0.34148 |
|
| Author affiliations | 0.33848 |
| registry data | 0.352221 |
| pregnancy | 0.494787 |
| Merck/CDC Pregnancy Registry | 0.401884 |
| congenital varicella syndrome | 0.960029 |
| high-risk period | 0.412878 |
| theoretical risk | 0.396419 |
| attenuated VZV | 0.357294 |
| adverse events | 0.35873 |
| New patient enrollment | 0.357673 |
| birth defects | 0.369427 |
| Sonja A. Rasmussen | 0.374062 |
| Immunization Safety Office | 0.360683 |
| varicella-zoster virus | 0.338347 |
| live-born infants | 0.389435 |
| exposure | 0.338361 |
| traditional childbearing ages | 0.363885 |
| Adverse Event Reporting | 0.359504 |
| confidence interval | 0.36206 |
| low birth weight | 0.367482 |
| pregnancy-related vaccine | 0.341156 |
| Varivax | 0.390297 |
| Mona Marin | 0.372237 |
|
CLICK HERE |
| 4897 |
Centers for Disease Control and Prevention |
Html |
en |
Regression Model Fitting With Quadratic Term Leads to Different Conclusion in Economic Analysis of Washington State Smoking Ban |
null |
| Figure. Comparison | 0.659381 |
| figure displays | 0.621704 |
| regression equations | 0.673284 |
| conclusions | 0.461026 |
| findings | 0.448823 |
| implementation | 0.441747 |
| Values | 0.445211 |
| Consumer Price Index | 0.805584 |
| regression fit | 0.722119 |
| official position | 0.61675 |
|
| smoke-free law | 0.687851 |
| inflation | 0.467363 |
| bars | 0.453954 |
| taxable retail sales | 0.901182 |
| Washington State | 0.647254 |
| Disease Control | 0.60679 |
| report | 0.435673 |
| taverns | 0.482539 |
| quarter | 0.507964 |
|
CLICK HERE |
| 7045 |
Centers for Disease Control and Prevention |
Html |
en |
Syphilis & MSM (Men Who Have Sex With Men) - CDC Fact Sheet |
Syphilis and MSM Fact Sheet from CDC. Why should MSM be concerned about syphilis? What is the link between syphilis and HIV? And more... |
| eye problems | 0.547967 |
| sexually transmitted infection | 0.613638 |
| severe medical problems | 0.575802 |
| sex partners | 0.544643 |
| United States | 0.6277 |
| swollen lymph nodes | 0.576604 |
| Prevention Information Network | 0.5677 |
| STD Prevention Conference | 0.578278 |
| P. O. Box | 0.565582 |
| STD information | 0.545041 |
| latent stage | 0.54451 |
| painless sores | 0.584265 |
| Transmitted Diseases Treatment | 0.571807 |
| Association (ASHA) | 0.56812 |
| fact sheet | 0.577798 |
| Disease Control | 0.58979 |
| STD Clinics | 0.545664 |
| secondary syphilis | 0.787417 |
| syphilis sores | 0.779091 |
| direct contact | 0.542343 |
| anal sex | 0.553109 |
| American Sexual Health | 0.56719 |
| sexually active man | 0.584651 |
| sexually -active person | 0.600827 |
|
| different signs | 0.584584 |
| sex partner | 0.562784 |
| Sexually Transmitted Disease | 0.589762 |
| oral sex | 0.548377 |
| MSM | 0.553645 |
| syphilis | 0.973773 |
| P&S syphilis cases | 0.797642 |
| vaginal sex | 0.58439 |
| swimming pools | 0.540599 |
| original site | 0.541567 |
| symptoms | 0.547758 |
| skin rash | 0.540632 |
| Sexually Transmitted Diseases | 0.631257 |
| STD Increases | 0.545569 |
| Tertiary syphilis | 0.768469 |
| health problems | 0.613062 |
| healthcare provider | 0.615259 |
| MMWR Recomm Rep | 0.565485 |
| Research Triangle Park | 0.565082 |
| P&S syphilis | 0.803512 |
| risk | 0.549294 |
| hot tubs | 0.541373 |
| HIV infection | 0.562322 |
|
CLICK HERE |
| 7379 |
Centers for Disease Control and Prevention |
Html |
en |
Pandemic Resources Tools - FluAid 2.0 |
FluAid is designed to assist state and local level planners in preparing for the next influenza pandemic by providing estimates of potential impact specific to their locality - CDC |
| software | 0.516625 |
| Download Stand-alone FluAid | 0.515788 |
| hospital beds | 0.478608 |
| maximum estimates | 0.497184 |
| sufficient hospital beds | 0.477245 |
| potential economic impact | 0.516629 |
| health outcomes | 0.641615 |
| necessary data specific | 0.480656 |
| outpatient visits | 0.535885 |
| general modeling philosophy | 0.479731 |
| potential impact specific | 0.593907 |
| level public health | 0.508244 |
| high risk condition | 0.485468 |
| state | 0.526028 |
| health care providers | 0.54387 |
| test version | 0.497184 |
| adverse health outcome | 0.49127 |
| influenza pandemic | 0.900051 |
| national level estimates | 0.749851 |
| public health planner | 0.488382 |
| national level model | 0.567344 |
| local level plans | 0.501764 |
| User’s Manual | 0.494661 |
| measurable economic impact | 0.502765 |
|
| national estimates | 0.508931 |
| non-high risk | 0.533774 |
| high risk | 0.557306 |
| after-the-event estimates | 0.498822 |
| gross attack rates | 0.47811 |
| national level impact | 0.519931 |
| Influenza pandemics | 0.514142 |
| influenza pandemic plan | 0.636715 |
| adverse health outcomes | 0.571102 |
| sustained human-to-human transmission | 0.487604 |
| pandemic influenza | 0.682812 |
| health care planner | 0.490443 |
| possible pandemic | 0.538755 |
| local level model | 0.619325 |
| user supply minimum | 0.482595 |
| potential impact | 0.790094 |
| influenza pandemic-related morbidity | 0.55149 |
| health care | 0.548209 |
| public health | 0.531596 |
| economic impact | 0.543038 |
| local level planners | 0.579442 |
| local health care | 0.496578 |
| local level | 0.702179 |
| FluAid | 0.623351 |
|
CLICK HERE |
| 8970 |
Centers for Disease Control and Prevention |
Html |
en |
Do a SWOT Analysis - Evaluate a CoP - Resource Kit |
null |
| CoP | 0.936944 |
| critical factors | 0.429565 |
| achievement | 0.24328 |
| reside | 0.25121 |
| swot analysis | 0.913257 |
| Template | 0.242045 |
| external factors | 0.815759 |
| weaknesses | 0.407833 |
| members | 0.283685 |
| context | 0.244333 |
| CoP activities | 0.537602 |
| threats | 0.382448 |
| goals | 0.272559 |
|
| area | 0.245949 |
| needs | 0.242467 |
| internal positive attributes | 0.525482 |
| method | 0.246401 |
| CoP functions | 0.803022 |
| internal attributes | 0.372225 |
| resources | 0.242517 |
| opportunities | 0.29055 |
| picture | 0.242342 |
| environment | 0.242742 |
| Internal factors | 0.412987 |
| decision-making | 0.24636 |
| strengths | 0.400165 |
|
CLICK HERE |
| 10314 |
Centers for Disease Control and Prevention |
Html |
en |
HAN Archive - 00326 - Hantavirus Pulmonary Syndrome Cases Associated with Staying in Yosemite National Park, California |
Health Alert Network (HAN). Provided by the Centers for Disease Control and Prevention (CDC). |
| non-cardiogenic pulmonary edema | 0.410483 |
| rodent urine | 0.333831 |
| Yosemite National Park | 0.971705 |
| canvas exterior sides | 0.407488 |
| clinically compatible illnesses | 0.407381 |
| Disease Control | 0.440059 |
| deer mice | 0.322578 |
| state health departments | 0.460252 |
| CDC’s Hantavirus | 0.397286 |
| CDC document | 0.363483 |
| ill persons | 0.341538 |
| health care providers | 0.467445 |
| additional information | 0.314082 |
| bilateral interstitial infiltrates | 0.418547 |
| gastrointestinal symptoms | 0.323338 |
| immediate medical attention | 0.405134 |
| solid walls | 0.314987 |
| Additional suspected cases | 0.428131 |
| Chest radiographs | 0.315974 |
| party exhibit symptoms | 0.416857 |
| multiple health jurisdictions | 0.456294 |
| hantavirus pulmonary syndrome | 0.49016 |
| zoonotic viral disease | 0.458433 |
| HPS symptoms | 0.662883 |
| Viral Special Pathogens | 0.41607 |
|
| California Department | 0.335239 |
| Boystown area | 0.321571 |
| CDC Health Alert | 0.548262 |
| small viral particles | 0.439265 |
| Public Health | 0.370714 |
| reportable disease | 0.329488 |
| clinical case definition | 0.402219 |
| HPS | 0.925657 |
| HAN Advisory | 0.326228 |
| enhances health decisions | 0.428261 |
| critical health issues | 0.433227 |
| state health department | 0.430434 |
| incubation period | 0.314923 |
| Notifiable Diseases | 0.316217 |
| Signature Tent Cabins | 0.948904 |
| Laboratory abnormalities | 0.314734 |
| toll-free Hantavirus Hotline | 0.435305 |
| recent exposure | 0.332952 |
| fatality rate | 0.325894 |
| National Park Service | 0.478193 |
| Current Case Definitions | 0.401042 |
| potential rodent exposure | 0.427972 |
| infected rodents | 0.33863 |
| serum LDH | 0.334131 |
|
CLICK HERE |
| 13046 |
Centers for Disease Control and Prevention |
Html |
null |
Vaccines: Rubella |
Rubella vaccine info for parents, public, and healthcare professionals |
|
|
CLICK HERE |
| 13461 |
Centers for Disease Control and Prevention |
Html |
en |
Announcement: Additional Guidance Online for ProvidersRegarding 9-Valent HPV Vaccine Use Among Persons Who PreviouslyReceived HPV Vaccination |
A 9-valent human papillomavirus (HPV) vaccine (Gardasil 9, Merck and Co., Inc.) was licensed for use in females and males in the United States in December 2014 (1,2). |
| 9-valent HPV vaccine | 0.905676 |
| intraepithelial neoplasia | 0.300345 |
| endorsement | 0.243912 |
| United States | 0.296292 |
| original MMWR paper | 0.345009 |
| U.S. Government Printing | 0.341234 |
| Human Services | 0.355663 |
| Drug Administration | 0.295274 |
| HPV vaccine | 0.955432 |
| Iversen OE | 0.29921 |
| Engl J Med | 0.297374 |
| Merck | 0.21703 |
| U.S. Department | 0.355872 |
| MMWR HTML versions | 0.348334 |
| MMWR readers | 0.285422 |
| character translation | 0.278144 |
| Immunization Practices | 0.291669 |
| Advisory Committee | 0.289091 |
| Inc. | 0.215566 |
| quadrivalent HPV vaccine | 0.794975 |
| electronic PDF version | 0.341683 |
| Giuliano AR | 0.291754 |
| CDC website | 0.302618 |
| 9-valent human papillomavirus | 0.395799 |
|
| format errors | 0.279857 |
| Co. | 0.215574 |
| females | 0.293214 |
| Additional information | 0.286916 |
| Health | 0.226139 |
| Contact GPO | 0.297862 |
| typeset documents | 0.28328 |
| trade names | 0.282911 |
| commercial sources | 0.282845 |
| official text | 0.277038 |
| males | 0.270911 |
| routine vaccination | 0.365289 |
| bivalent HPV vaccine | 0.673693 |
| current prices | 0.278786 |
| ACIP recommendations | 0.313913 |
| non-CDC sites | 0.28156 |
| HPV vaccines | 0.514807 |
| original paper copy | 0.339166 |
| et al | 0.282452 |
| report | 0.227941 |
| Joura EA | 0.286551 |
| electronic conversions | 0.277162 |
| vaccine (http://www.cdc.gov/vaccines/who/teens/downloads/9vHPV-guidance.pdf). | 0.627483 |
|
CLICK HERE |
| 14621 |
Centers for Disease Control and Prevention |
Html |
en |
Flexible Roles for American Indian Elders in Community-BasedParticipatory Research |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| American Indian community | 0.533045 |
| monthly elders | 0.52053 |
| regular CAB meetings | 0.477265 |
| project | 0.533842 |
| Ment Health Res | 0.468332 |
| research process | 0.496915 |
| american indian elders | 0.962406 |
| American Indian adolescents | 0.517709 |
| American Indian people | 0.485494 |
| academic partners | 0.482645 |
| life narratives | 0.5039 |
| elders members | 0.540384 |
| Indian Center staff | 0.464925 |
| community advisory board | 0.497383 |
| health promotion initiatives | 0.483506 |
| research project outline | 0.473221 |
| American Indian communities | 0.531042 |
| community health | 0.486995 |
| decision making | 0.462917 |
| American Indian worldview | 0.484882 |
| formal agreements | 0.54492 |
| conduct prevention research | 0.462723 |
| CAB meetings | 0.602896 |
| interview guide | 0.482703 |
|
| community health initiative | 0.467369 |
| community members | 0.48725 |
| CAB members | 0.562611 |
| quiet elders | 0.542756 |
| consensus panels | 0.724738 |
| American Indian worldviews | 0.48148 |
| Indian Center board | 0.47441 |
| community-based participatory research | 0.704274 |
| consensus panel participants | 0.470525 |
| public health | 0.565502 |
| outspoken elders | 0.519263 |
| health promotion curriculum | 0.492836 |
| community partners | 0.473686 |
| Native Ment Health | 0.468482 |
| Tucson Indian Center | 0.652601 |
| American Indian cultures | 0.510555 |
| American Indian Resilience | 0.519524 |
| urban american indian | 0.56563 |
| elder project engagement | 0.470415 |
| consensus panel | 0.563258 |
| community health priorities | 0.467539 |
| Enid Zuckerman College | 0.47741 |
| historical trauma | 0.485983 |
| research project | 0.474345 |
|
CLICK HERE |
| 14637 |
Centers for Disease Control and Prevention |
Html |
en |
Controlling Mosquitoes at Home |
Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention. |
| door screens | 0.34856 |
| air conditioning | 0.356272 |
| turn | 0.209434 |
| Cover open vent | 0.587954 |
| humid areas | 0.415336 |
| plumbing pipes | 0.365288 |
| rain barrels | 0.401579 |
| patio furniture | 0.357409 |
| indoor insect spray* | 0.560805 |
| septic tank | 0.371844 |
| insecticides | 0.243685 |
| holes | 0.21127 |
| water storage containers | 0.700419 |
| mosquitoes | 0.95193 |
| treat areas | 0.344198 |
|
| eggs | 0.30525 |
| flowerpot saucers | 0.788781 |
| trash containers | 0.461751 |
| buckets | 0.247119 |
| wire mesh | 0.631261 |
| outdoor insect spray | 0.608952 |
| large containers | 0.428688 |
| adult mosquito | 0.656529 |
| scrub | 0.250816 |
| label directions | 0.344589 |
| indoor insect fogger* | 0.561496 |
| humid places | 0.402682 |
| label instructions | 0.352154 |
| laundry room | 0.343622 |
|
CLICK HERE |